{"disease":{"id":"anderson-fabry-disease","name":"anderson fabry disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06607471","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT07382128","title":"Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT04943991","title":"Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Wuerzburg University Hospital","has_results":false},{"nct_id":"NCT04043273","title":"Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences","phase":"","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Amicus Therapeutics France SAS","has_results":false},{"nct_id":"NCT02956954","title":"Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"University Hospital, Rouen","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}